Newborn screening
Reference (74)
- et al.
Influence of phenylalanine intake on phenyketonuria
Lancet
(1953) - et al.
Preliminary report on a mass screening program for neonatal hypothyroidism
J Pediatr
(1975) - et al.
Biotinidase deficiency
Adv Pediatr
(1991) Galactosemia: screening and diagnosis
Clin Biochem
(1991)- et al.
Maternal phenylketonuria: an international study
Mol Genet Metab
(2000) - et al.
More evidence to favour newborn screening for cystic fibrosis
Lancet
(2007) - et al.
The influence of newborn screening for cystic fibrosis on pulmonary outcomes in New South Wales. 147
(2005) - et al.
Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies
J Pediatr
(1995) - et al.
Screening for cystic fibrosis: feasibility of molecular genetic analysis of dried blood specimens
Biochem Med Metab Biol
(1991) - et al.
Newborn screening for congenital adrenal hyperplasia in New Zealand
J Pediatr
(1995)
Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction
Steroids
(2006)
A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing
Clin Biochem
(2005)
Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency
Am J Hum Genet
(2001)
Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study
Lancet
(2007)
Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c 985A > G identified by neonatal screening
Mol Genet Metab
(2005)
Newborn screening for lysosomal storage disorders
Mol Genet Metab
(2006)
Chemical chaperone rescue of mutant human cystathionine beta-synthase
Mol Genet Metab
(2007)
Uber Ausscheidung von Phenylbrenztraubensaur in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillitat
Z Physiol Chem
(1934)
Treatment of phenylketonuria with a diet low in phenylalanine
Br Med J
(1955)
A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants
Pediatries
(1963)
Newborn phenylketonuria detection program in Massachusetts
Am J Public Health Nations Health
(1964)
Is hereditary histidinaemia harmful?
Lancet
(1974)
Early detection of neonatal hypothyroidism by serial TSH determination in dried blood. Six months experience with a reliable, efficient and inexpensive method
Helv Paediatr Acta
(1977)
A pilot newborn screening for congenital adrenal hyperplasia in Alaska
J Clin Endocrinol Metab
(1982)
Worldwide experience in newborn screening for classical congential adrenal hyperplasia due to 21-hydroxylase deficiency
Pediatrics
(1988)
Dried-blood spot screening for cystic fibrosis in the newborn
Lancet
(1979)
Neonatal screening for sickle cell disease
Cochrane Database Syst Rev
(2000)
Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism
J Inherit Metab Dis
(1990)
DNA microextraction from dried blood spots on filter paper blotters: potential applications to newborn screening
Hum Genet
(1987)
Experience with screening newborns for Duchenne muscular dystrophy in Wales
BMJ
(1993)
Newborn screening for Duchenne muscular dystrophy
Arch Dis Child
(2003)
Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy
Expert Opin Biol Ther
(2007)
Readthrough strategies for stop codons in Duchenne muscular dystrophy
Acta Myol
(2006)
Principies and Practice of Screening for Disease.
Geneva: World Health Organization
(1968)
The Metabolic and Molecular Bases of Inherited Disease.
Cited by (0)
Copyright © 2008 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.